WallStreetZenWallStreetZen

NASDAQ: BIOA
Bioage Labs Inc Stock Ownership - Who owns Bioage Labs?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Bioage Labs Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Paul D. RubinChief Medical Officer2026-03-027,433$20.30
$150.89kSell
Paul D. RubinChief Medical Officer2026-03-022,000$6.57
$13.14kBuy
Paul D. RubinChief Medical Officer2026-03-025,433$4.11
$22.33kBuy
Dov A. Md GoldsteinChief Financial Officer2026-03-013,542$4.38
$15.51kBuy
Paul D. RubinChief Medical Officer2026-02-022,000$6.57
$13.14kBuy
Paul D. RubinChief Medical Officer2026-02-025,433$4.11
$22.33kBuy
Paul D. RubinChief Medical Officer2026-02-027,433$18.75
$139.37kSell
Dov A. Md GoldsteinChief Financial Officer2026-02-013,541$4.38
$15.51kBuy
Dov A. Md GoldsteinChief Financial Officer2026-01-163,542$4.38
$15.51kBuy
Kristen FortneyChief Executive Officer2026-01-13233,107$18.12
$4.22MSell

1 of 3

BIOA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BIOA insiders and whales buy or sell their stock.

BIOA Shareholders

What type of owners hold Bioage Labs Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vijay Satyanand Pande7.29%3,233,170$52.22MInsider
A16z Capital Management LLC7.29%3,233,170$52.22MInstitution
James Healy5.19%2,304,901$37.22MInsider
Sofinnova Investments Inc5.17%2,293,788$37.04MInstitution
Cormorant Asset Management LP4.60%2,040,605$32.96MInstitution
Patrick G. Enright3.85%1,710,589$27.63MInsider
Cormorant Asset Management LP3.67%1,629,529$26.32MInsider
Octagon Capital Advisors LP3.60%1,598,000$25.81MInstitution
Blackrock Inc3.44%1,527,541$24.67MInstitution
Vanguard Group Inc3.19%1,414,770$22.85MInstitution

1 of 3

BIOA vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BIOA53.01%22.29%Net SellingNet Selling
TLRY9.64%17.71%Net BuyingNet Buying
ESPR58.90%16.57%Net SellingNet Selling
ETON58.24%32.85%Net SellingNet Buying
EVO5.54%0.00%
View Top Pharmaceutical Stocks

Bioage Labs Stock Ownership FAQ

Who owns Bioage Labs?

Bioage Labs (NASDAQ: BIOA) is owned by 53.01% institutional shareholders, 22.29% Bioage Labs insiders, and 24.69% retail investors. Vijay Satyanand Pande is the largest individual Bioage Labs shareholder, owning 3.23M shares representing 7.29% of the company. Vijay Satyanand Pande's Bioage Labs shares are currently valued at $51.18M.

If you're new to stock investing, here's how to buy Bioage Labs stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.